Skip to main content
Log in

Effect of Omeprazole on Diazepam Disposition in the Rat: in Vitro and in Vivo Studies

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. The inhibitory effects of omeprazole on diazepam metabolism in vitro and in vivo are compared in the rat.

Methods. 3-hydroxylation and N-demethylation of diazepam was investigated in the presence of a range of omeprazole concentrations (2-500µM) in hepatic microsomes and hepatocytes. Zero order infusions together with matched bolus doses of omeprazole were used to achieve a range of steady state plasma concentrations (10-50mg/ L) and to study the diazepam-omeprazole interaction in vivo.

Results. The 3-hydroxlation pathway was more prone to inhibition (KIs 108 ± 30 and 28 ± 11 µM in microsomes and hepatocytes, respectively) than the demethylation pathway (KIs of 226 ± 76 and 59 ± 27 µM in microsomes and hepatocytes, respectively). In both in vitro systems, the mechanism of inhibition was competitive with Km/KI ratios larger than 1 for the 3HDZ pathway and smaller than 1 for the NDZ pathway. There was an omeprazole concentration dependent decrease in diazepam clearance in vivo which could be modelled using a simple inhibition equation with a KI of 57µM (19.8mg/L). In contrast there was no statistically significant change in the steady state volume of distribution for diazepam in the presence of omeprazole.

Conclusions. The in vivo KI for the omeprazole: diazepam inhibition interaction shows closer agreement with the KI values obtained in hepatocytes than with those observed in microsomes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. O. Pelkonen and J. Puurunen. The effect of cimetidine on in vitro and in vivo microsomal drug metabolism in the rat. Biochem. Pharmac. 29: 3075–3080 (1982).

    Google Scholar 

  2. M. Passanen, T. Taskinen, M. Iscan, E. A. Sotaniemi, M. Kairaluoma and O. Pelkonen. Inhibition of human hepatic and placental xenobiotic monooxygenases by imidazole antimycotics. Biochem. Pharmac. 37: 3861–3866 (1988).

    Google Scholar 

  3. I. Skånberg, K-J. Hoffmann and C. G. Regårdh. Pharmacokinetics and metabolism of omeprazole in animals. Scan. J. Gastroenterol. 21: 92–93 (1986).

    Google Scholar 

  4. K-J. Hoffmann. Identification of the main urinary metabolites of omeprazole after an oral dose to rats and dogs. Drug Metab. Disp. 14: 341–348 (1986).

    Google Scholar 

  5. R. Gugler and J. C. Jensen. Omeprazole inhibits oxidative drug metabolism. Gastroenterol. 89: 1235–1241 (1985).

    Google Scholar 

  6. T. Andersson, K. Andrén, C. Cederberg, G. Edvardsson, A. Heggelund and P. Lundborg. Effect of omeprazole and cimetidine on plasma diazepam levels. Eur. J. Clin. Pharmac. 39: 51–54 (1990).

    Google Scholar 

  7. G. R. Wilkinson. Clearance approaches in pharmacology. Pharmac. Rev. 39: 1–47 (1987).

    Google Scholar 

  8. J. D. Davies, L. Aarons and J. B. Houston. Relationship between enoxacin and ciprofloxacin plasma concentrations and theophylline disposition. Pharm. Res. 11: 1424–1428 (1994).

    Google Scholar 

  9. K. A. Hayes, B. Brennan, R. Chenery and J. B. Houston. In vivo disposition of caffeine predicted from hepatic microsomal and hepatocyte data. Drug Metab. Disp. 23: 349–353 (1995).

    Google Scholar 

  10. P. E. B. Reilly, D. A. Thompson, S. R. Mason and W. D. Hooper. Cytochrome P450IIIA enzymes in rat liver microsomes: involvement in C3-hydroxylation of diazepam and nordazepam but not N-delakylation of diazepam and temazepam. Mol. Pharmac. 37: 767–774 (1990).

    Google Scholar 

  11. K. Zomorodi, D. J. Carlile and J. B. Houston. Kinetics of diazepam metabolism in rat hepatic microsomes and hepatocytes and their use in predicting in vivo hepatic clearance. Xenobiotica, in press.

  12. K. Zomorodi and J. B. Houston. Diazepam-Omeprazole inhibition interaction: An in vitro investigation using human liver microsomes. Submitted for publication.

  13. K. Watanabe, K. Furuno, K. Eto, R. Oishi and Y. Gomita. First-pass metabolism of omeprazole in rats. J. Pharm. Sci. 83: 1131–1134 (1994).

    Google Scholar 

  14. U. Klotz, K. H. Antonin and P. R. Beick. Pharmacokinetics and plasma binding of diazepam in man, dog, rabbit, guinea pig and rat. J. Pharmac. Exp. Therap. 199: 67–73 (1976).

    Google Scholar 

  15. R. B. Sewell, C. W. Brook, G. W. Mihaly, D. J. Morgan and R. A. Smallwood. Intracellular binding is an important determinant of the avid hepatic uptake of the high clearance drug omeprazole. Biochem. Pharmac. 48: 846–849 (1994).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zomorodi, K., Houston, J.B. Effect of Omeprazole on Diazepam Disposition in the Rat: in Vitro and in Vivo Studies. Pharm Res 12, 1642–1646 (1995). https://doi.org/10.1023/A:1016241000480

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1016241000480

Navigation